F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.89 EUR 0.53% Market Closed
Market Cap: 700.1m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Fluidigm Corp
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fluidigm Corp
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluidigm Corp
F:FLB
Other Non-Cash Items
$3.1m
CAGR 3-Years
-46%
CAGR 5-Years
-35%
CAGR 10-Years
-17%
Thermo Fisher Scientific Inc
NYSE:TMO
Other Non-Cash Items
$700m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Other Non-Cash Items
$760m
CAGR 3-Years
23%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Other Non-Cash Items
$19.1m
CAGR 3-Years
4%
CAGR 5-Years
41%
CAGR 10-Years
26%
Agilent Technologies Inc
NYSE:A
Other Non-Cash Items
$186m
CAGR 3-Years
64%
CAGR 5-Years
12%
CAGR 10-Years
1%
IQVIA Holdings Inc
NYSE:IQV
Other Non-Cash Items
$186m
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

Fluidigm Corp
Glance View

Market Cap
703.6m EUR
Industry
Life Sciences Tools & Services

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

FLB Intrinsic Value
0.67 EUR
Overvaluation 64%
Intrinsic Value
Price
F

See Also

What is Fluidigm Corp's Other Non-Cash Items?
Other Non-Cash Items
3.1m USD

Based on the financial report for Sep 30, 2024, Fluidigm Corp's Other Non-Cash Items amounts to 3.1m USD.

What is Fluidigm Corp's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
-17%

Over the last year, the Other Non-Cash Items growth was -77%. The average annual Other Non-Cash Items growth rates for Fluidigm Corp have been -46% over the past three years , -35% over the past five years , and -17% over the past ten years .

Back to Top